Select your language

  • EN
  • FR

abionyx linkedin 1ff75abionyx twitter b3bc9

logo abionyx new21

  • Home
  • About
    • About
    • Abionyx
    • Management
    • Board of Directors
    • Specialized Committees
      • - Audit Committee
      • - Remuneration Committee
    • Scientific Advisory Board
  • Our Assets
    • Our Assets
    • CER 001
    • CER 002
    • CER 209
  • Indications
    • LCAT
    • Sepsis
    • COVID
  • Media
    • Media
    • Press releases
    • ABIONYX in the media
  • Investors
    • Investors
    • Regulated information
    • Shareholder meeting
    • Analyst Research
    • Abionyx on stock market
    • Investor Contacts
    • Financial Calendar

abionyx

  • Media
  • Press releases
  • ABIONYX in the media

ABIONYX announces the signing of a strategic partnership with GTP Biologics (Fareva Group) and V-Nano (VBI Therapeutics group) for the bioproduction of the bio-HDL CER-001 in France

  • Fichier: abionyx_pr_bioproduction_9c9cb.pdf
  • Contact
  • Legal notice
  • Processing of personal data
  • Privacy policy
  • General purchase conditions
  • General terms and conditions for procurement of services
© 2025 Abionyx : A new generation biotech company
Back to top